4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001171843-24-005964
Options or other derivatives
- Chief Executive Officer acquired 326,710 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Nijhawan Pardeep Chief Executive Officer | 2024-10-30 | Grant or award · Series A-1 Convertible Preferred Shares | +150 | 150 | I: show line 1 in the form | |||||
| Nijhawan Pardeep Chief Executive Officer | 2024-10-30 | Grant or award · Warrants (right to buy) | +326,560 | 326,560 | I: show line 2 in the form |
Loading xslF345X05/ownership.xml…